-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on CME Group, Raises Price Target to $310

Benzinga·10/22/2026 19:40:03
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $270 to $310.